The Interventional Invasive Segment is a $100M global P&L within the Clinical Systems Interventional business. This is a business leader position reporting directly to the CS Interventional Vice President and General Manager and is responsible for creating an Interventional Invasive Monitoring P&L as well as driving our overall business strategy for the segment globally. Provide direct and dotted-line leadership to the Interventional Invasive team in the areas of R & D, Marketing, Sales and Operations.